Skip to content

Clinical trials

Phase 3 Lung Neoplasms trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 3 Country / region: Israel Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20061
20071
20081
20091
20101
20121
20131
20152
20191
20201
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting4
Active, not recruiting3
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Bristol-Myers Squibb2
Gustave Roussy, Cancer Campus, Grand Paris2
Pfizer2
Achieve Life Sciences1
Alliance for Clinical Trials in Oncology1
Amgen1
Boehringer Ingelheim1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms21
Carcinoma, Non-Small-Cell Lung14
Adenocarcinoma of Lung3
Carcinoma3
Neoplasm Metastasis2
Anemia1
Lung Diseases1
Neoplasms1
Pleural Effusion1
Pleural Effusion, Malignant1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.